Abstract:The type III secretion system of Escherichia coli O157:H7 is involved in colonization of mammalian hosts by the organism. The translocated intimin receptor (Tir) is inserted into the mammalian host cell plasma membrane in a hairpin loop topology with the central loop of the molecule exposed to the host cell surface and accessible for interaction with an LEE-encoded bacterial outer membrane adhesin called intimin. Shiga toxin type 1 and 2 produced by E. coli O157:H7 are responsible for hemolytic uremic syndrome and able to promote intestinal colonization. Zonula occludens toxin (Zot) is a single polypeptide chain encoded by the filamentous bacteriophage CTXφ of Vibrio cholerae. Zot binds a receptor on intestinal epithelial cells and increases mucosal permeability by affecting the structure of epithelial tight junctions. Because of these properties, Zot is a promising tool for mucosal drug and antigen (Ag) delivery. In the current study, we constructed a novel fusion protein carrying both of the immunogenic B subunits derived from the two toxins, Tir and Zot, designated Stx2B–Tir–Stx1B–Zot, expressed in the E. coli BL21 and harvested the purified protein by a simple GST·Bind Resin chromatography method. We used a streptomycin-treated mouse model to evaluate the efficacy of subcutaneous vs. intranasal administration of the vaccine. Following immunization, mice were infected with E. coli O157:H7 and feces were monitored for shedding. Immune responses against Stx2B–Tir–Stx1B–Zot, Stx2B–Tir–Stx1B and control agent (GST/PBS) were also monitored. Subcutaneous immunization of mice with Stx2B–Tir–Stx1B–Zot induced significant Stx2B–Tir–Stx1B–Zot-specific serum IgG antibodies but did not significantly induce any antigen-specific IgA in feces, whereas intranasal immunization elicited significant Stx2B–Tir–Stx1B–Zot-specific serum IgG antibodies with some animals developing antigen-specific IgA in feces. Mice that were immunized intranasally with Stx2B–Tir–Stx1B–Zot showed dramatically decreased E. coli O157:H7 shedding compared to those of Stx2B–Tir–Stx1B and control agent following experimental infection. Mice immunized subcutaneously with Stx2B–Tir–Stx1B–Zot or Stx2B–Tir–Stx1B both showed reduced shedding in feces, moreover, Stx2B–Tir–Stx1B–Zot did better. These results demonstrate the perspective for the use of Stx2B–Tir–Stx1B–Zot to prevent colonization and shedding of E. coli O157:H7.

Immuno-protection of Intimin and Tir-Tccp Recombinant Protein of Enterohaemorrhagic Escherichia Coli O157 : H7 to Balb/c Mice

Protective Immunity in Mice Induced by EHEC O157 △ Ler/stx (Pbr322::stx1/2b::eae)

Immunogenicity Of Recombinant Porcine Attaching And Effacing-Associated Protein Compared With Intimin Fragment In Escherichia Coli O157:H7-Infected Mice

[The Study for the Immuno-Protection of E. Coli O157:H7 Outer Membrane Protein].

Immunization with the MipA, Skp, or ETEC_2479 Antigens Confers Protection against Enterotoxigenic E. coli Strains Expressing Different Colonization Factors in a Mouse Pulmonary Challenge Model

Targeting Peptide‐enhanced Antibody and CD11c+ Dendritic Cells to Inclusion Bodies Expressing Protective Antigen Against ETEC in Mice

Expression of Fusion Protein Stx2B-Tir-Stx1B from Enterohemorrhagic Escherichia Coli O157: H7 and Its Immunogenicity Analysis in BALB/c Mice

Intragastric Immunization of Mice with Enterohemorrhagicescherichia Colio157:H7 Bacterial Ghosts Reduces Mortality and Shedding and Induces a Th2-type Dominated Mixed Immune Response

Novel fusion protein protects against adherence and toxicity of enterohemorrhagic Escherichia coli O157:H7 in mice.

Enterohemorrhagic Escherichia Coli Trivalent Recombinant Vaccine Containing EspA, Intimin and Stx2 Induces Strong Humoral Immune Response and Confers Protection in Mice.

Immune effect in mice administered orally with recombinant Bacillus subtilis spores expressing OmpC of Salmonella pullorum by using CotB as a fusion partner

[Immunoprotective Effects of Helicobacter Pylori UreB and HpaA Bivalence Recombinant Vaccine with Inner Adjuvant on Experimental Infection in Mice].

Immunization with Recombinant Lactobacillus Casei Strains Producing K99, K88 Fimbrial Protein Protects Mice Against Enterotoxigenic Escherichia Coli.

Immunization of mice with Lactobacillus casei expressing intimin fragments produces antibodies able to inhibit the adhesion of enteropathogenic Escherichia coli to cultivated epithelial cells.

Probiotic Enterococcus faecalis surface-delivering key domain of EtMIC3 proteins: immunoprotective efficacies against Eimeria tenella infection in chickens

Subcutaneous and intranasal immunization with Stx2B-Tir-Stx1B-Zot reduces colonization and shedding of Escherichia coli O157:H7 in mice.

Protective Efficacy of a Novel Multivalent Vaccine in the Prevention of Diarrhea Induced by Enterotoxigenic Escherichia Coli in a Murine Model

Experimental Infection of Specific‐Pathogen‐Free Mice with Enterohemorrhagic Escherichia Coli 0157: H7

An Attenuated Escherichia coli K88ac LT(S63K) Δ STb Efficiently Provides Protection Against Enterotoxigenic Escherichia coli in the Mouse Model

INDUCTION OF IMMUNE RESPONSES IN MICE AFTER ORAL IMMUNIZATION WITH RECOMBINANT LACTOBACILLUS CASEI STRAINS EXPRESSING ENTEROTOXIGENICESCHERICHIA COLI F41 FIMBRIAL PROTEIN

Protective Effects of Fusion Protein of Hsp65-MOMP-T-epitopes on C. Trachomatis Genital Tract Infection of Mice